15 Feb 2026
New horizons in structural heart disease therapy - Cutting-edge stroke prevention devices: WATCHMAN × SENTINEL
Sponsored by Boston Scientific
Spokesperson:
M. Asami
Discussant:
D. Hachinohe
Summary
This session explores the latest advancements in stroke prevention for patients undergoing transcatheter aortic valve implantation (TAVI) with atrial fibrillation. It highlights left atrial appendage closure (LAAC) as an emerging therapy, the evolution of LAAC devices, and the critical role of perioperative stroke prevention using the SENTINEL Cerebral Protection System. Practical guidelines and clinical considerations for safe implementation are comprehensively discussed.
Learning Objectives
- To learn about LAAC as a new therapy for stroke prevention after TAVI in patients with atrial fibrillation, and the importance of stroke prevention during the perioperative phase of TAVI
- To know the latest insights on LAAC device evolution and post-procedural anticoagulation therapy
- To learn about the need for stroke prevention during TAVI perioperatively and the potential of the SENTINEL Cerebral Protection System, guidelines for appropriate use for safe implementation, and considerations for its application in actual clinical practice